HHLR Advisors’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-382,606
| Closed | -$597K | – | 54 |
|
|
2024
Q4 | $597K | Hold |
382,606
| – | – | 0.02% | 41 |
|
|
2024
Q3 | $1.4M | Hold |
382,606
| – | – | 0.03% | 39 |
|
|
2024
Q2 | $1.27M | Hold |
382,606
| – | – | 0.03% | 67 |
|
|
2024
Q1 | $1.63M | Hold |
382,606
| – | – | 0.04% | 53 |
|
|
2023
Q4 | $689K | Hold |
382,606
| – | – | 0.01% | 45 |
|
|
2023
Q3 | $761K | Hold |
382,606
| – | – | 0.02% | 53 |
|
|
2023
Q2 | $979K | Sell |
382,606
-148,086
| -28% | -$379K | 0.02% | 54 |
|
|
2023
Q1 | $2.13M | Sell |
530,692
-233,714
| -31% | -$937K | 0.04% | 60 |
|
|
2022
Q4 | $1.02M | Hold |
764,406
| – | – | 0.02% | 62 |
|
|
2022
Q3 | $1.51M | Hold |
764,406
| – | – | 0.04% | 56 |
|
|
2022
Q2 | $1.82M | Hold |
764,406
| – | – | 0.04% | 59 |
|
|
2022
Q1 | $3.09M | Hold |
764,406
| – | – | 0.06% | 53 |
|
|
2021
Q4 | $8.39M | Buy |
+764,406
| New | +$8.39M | 0.13% | 53 |
|